Our Projects

Unitaid's projects are the life blood of our business. Our funding allows innovative medications, diagnostics tools and public-health techniques to be introduced in developing countries speedily and at an affordable price.

Whether they address HIV/AIDS, tuberculosis, malaria or hepatitis C, all our grants have one thing in common: they bring the best that science has to offer and put it to work for those in need. Browse our projects below to find out more about the transformative work that Unitaid grants are funding.

Filters / Search

Grant focus
Negotiate licences to enable the manufacture of low-cost, high-quality HIV, hepatitis C and tuberculosis medicines for developing countries

Lead Grantee
Medicines Patent Pool

Status
Active

Amount
US $60,367,000

Disease
Multiple

The Medicines Patent Pool

View More

Grant focus
Make artesunate more widely available to treat children with severe malaria

Lead Grantee
Medicines for Malaria Venture (MMV)

Status
Active

Amount
US $34,000,000

Disease
Malaria

Better treatment for severe malaria

View More

Grant focus
Provide appropriate-strength paediatric TB drugs and develop new formulations for children under five years old

Lead Grantee
Global Drug Facility (GDF)

Status
Closed

Amount
US $13,144,000

Disease
Tuberculosis

Paediatric tuberculosis project

View More

Grant focus
Protect 25 million children from seasonal malaria in Africa’s Sahel region

Lead Grantee
Malaria Consortium

Status
Active

Amount
US $68,212,000

Disease
Malaria

Seasonal malaria chemoprevention for children in the Sahel

View More

Grant focus
Develop a better formulation of a key component of paediatric ARV regimens and promote in-country adoption of “4-in-1” fixed-dose formulations

Lead Grantee
Drugs for Neglected Diseases Initiative (DNDi)

Status
Active

Amount
US $17,335,404

Disease
HIV

Better HIV treatment for infants and young children

View More

Grant focus
Reduce transmission and mortality of multidrug-resistant TB (MDR-TB) and strengthen the market for drugs to treat it

Lead Grantee
Partners in Health (PIH)

Status
Active

Amount
US $60,369,772

Disease
Tuberculosis

Expand new drug markets for TB (endTB)

View More

Grant focus
Combat insecticide resistance in mosquitoes with new vector-control tools.

Lead Grantee
Innovative Vector Control Consortium (IVCC)

Status
Active

Amount
US $65,105,000

Disease
Malaria

Investing in new insecticides to combat malaria

View More

Grant focus
Create a market for the most effective malaria treatments through a private-sector subsidy

Lead Grantee
The Global Fund

Status
Closed

Amount
US $210,971,000

Disease
Malaria

Affordable medicines for malaria

View More

Sign Up for Unitaid Updates

  • This field is for validation purposes and should be left unchanged.